Feed aggregator
Blocking a key protein protects against metabolic liver damage
Obesity-related metabolic liver disease affects hundreds of millions of people worldwide, but only some fraction of those livers develop scarring, become inflamed, and eventually fail. University of Utah researchers have identified a protein, EFHD1, that appears to drive that transition by triggering an out-of-place antiviral immune response.
UNC researcher wins major grant to study the role of endoplasmic reticulum in T-cell metabolism
Jessica Thaxton, PhD, MsCR, associate professor in the Department of Cell Biology and Physiology at the UNC School of Medicine and co-leader of the Cancer Cell Biology Research Program at UNC Lineberger Comprehensive Cancer Center, has been awarded a prestigious $700,000 grant from the Mathers Foundation to support research into the role of the endoplasmic reticulum in T-cell metabolism and cancer development.
PCORI funding awarded to study symptom management for rare cholestatic liver diseases
The Patient-Centered Outcomes Research Institute (PCORI) has announced a $13 million funding award to the University of North Carolina at Chapel Hill over five years to study innovative symptom management interventions for patients with rare cholestatic liver diseases.
Antifungal medication may reduce inflammatory bowel disease symptoms
A commonly used systemic antifungal medication may help reduce symptoms in a subset of patients with inflammatory bowel disease (IBD) by restoring a healthier gut microbiome, according to a preliminary study by Weill Cornell Medicine investigators.
Penn Medicine tests FLASH proton therapy for cancer patients
A new form of proton therapy-designed to deliver cancer-killing radiation therapy in less than a second, through fewer total sessions, with potentially less risk of damaging side effects-is now being tested in a Phase I clinical trial at the Abramson Cancer Center of the University of Pennsylvania.
Host-targeting drugs offer new way to fight flu resistance
A drug that targets the host rather than the virus could get around the problem of anti-viral resistance. Every year, hundreds of thousands of people die of seasonal influenza, caused by infection with influenza A and B viruses.
Estrogen hormone combination may help relieve menopausal brain fog
Many women going through menopause report struggling with memory lapses, trouble concentrating and slower thinking, a set of symptoms often described as "brain fog."
Study reveals how melanoma weakens skin cell immune defenses
Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival, and spread.
Study identifies 36 risk genes for OCD and tic disorders
A Rutgers-led international collaboration has identified 36 genes that substantially raise the risk for obsessive-compulsive disorder (OCD) and chronic tic disorders – providing what two researchers said is the most detailed biological understanding of how these conditions develop – and how they might eventually be treated.
Review highlights challenges in managing childhood enterovirus infections
Enteroviruses (EVs) are a diverse group of viruses and a common cause of multiple infections in children.
MS patients' quality of life associated with walking performance and functional capacity
A study by the University of Eastern Finland found that quality of life in people with multiple sclerosis (MS) is strongly associated with their walking performance and functional capacity.
Study identifies three distinct BMI trajectories among people with type 2 diabetes
A recent study by the University of Eastern Finland identified three distinct body mass index (BMI) trajectories among people with type 2 diabetes.
Study links human gut bacteria to levels of key chemicals in the brain
The neuroactive potential of bacteria living in the human gut is associated with levels of key chemicals in the brain, according to a new study from the University of Surrey and the University of Roehampton.
Immunotherapy shows potential for treating rising gynecological tumors
Gynecological tumors, including cervical cancer (CC), endometrial cancer (EC), and ovarian cancer (OC), represent a significant global health burden for women.
Coronary angiography can be safely delayed after out-of-hospital cardiac arrest without ST elevation
Immediate coronary angiography did not improve 30-day survival compared with a deferred strategy in patients without an ECG ST-elevation after out-of-hospital cardiac arrest.
Multiple sclerosis treatment approach developed at Mainz University moves toward clinical application
A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application.
Targeted MS treatment protects the overall immune system
UZH researchers have developed a novel therapy for multiple sclerosis that is designed to stop the misguided immune response without suppressing the immune system as a whole.
BeOne Medicines announces voluntary agreement with U.S. Government to expand access to innovative cancer medicines
BeOne Medicines, Ltd., a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale.
Early baby swimming linked to a small IQ advantage by preschool age
A prospective cohort study of 1,935 mother-child pairs examined whether baby swimming during the first 6 months of life was associated with IQ and cognitive performance at ages 4 to 6 years. Swimming participation was associated with modestly higher scores across several cognitive domains, but the researchers cautioned that the observational findings cannot establish causation and may partly reflect socioeconomic and family-level differences.
Early-onset bowel cancer shows distinct biological and clinical features
One of Australia's largest real world studies of younger adults with advanced bowel cancer has identified important differences between cancers diagnosed before and after the age of 50, which could help doctors tailor treatments for younger adults more effectively.




